Skip To Content

News

All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.


Life-changing Drug Trikafta Submitted to Health Canada for Ages Six to Eleven
October 28, 2021
Read More
MANITOBA BECOMES FINAL PROVINCE TO COMMIT TO LIST LIFE CHANGING CYTIC FIBROSIS DRUG
October 22, 2021

CF Canada calls on the Northwest Territories, Nunavut and Federal Drug Programs to Fund Trikafta 

Read More
NEWFOUNDLAND AND LABRADOR HONOURS COMMITMENT TO FUND CYSTIC FIBROSIS DRUG TRIKAFTA 
October 20, 2021

All Atlantic Canada provinces have confirmed commitment to fund the drug 

Read More
YUKON MAKES HISTORY AS FIRST TERRITORY TO FUND TRIKAFTA
October 18, 2021

Cystic Fibrosis Canada calls on remaining jurisdictions to fund the drug 

Read More
PEI HONOURS COMMITMENT TO FUND CYSTIC FIBROSIS DRUG TRIKAFTA
October 15, 2021

Newfoundland and Labrador is the only Atlantic Canada province yet to confirm it will fund the drug. Prince Edward Island (PEI) is the latest province to announce it will fund the transformational cystic fibrosis drug, Trikafta.

Read More
British Columbia Becomes Fifth Province to List Miracle Cystic Fibrosis Drug, Trikafta
October 6, 2021
Read More
Open letter from CF clinicians calling upon provincial governments to make Trikafta accessible to everyone who could benefit from it
October 1, 2021

Over 50 CF medical experts from across Canada have added their names to the open letter to provincial governments calling for access for everyone who could benefit from it.  

Read More
Cystic Fibrosis Canada launches Elevate to ensure work is guided by people impacted by disease
September 30, 2021

Community consultation program will enable people impacted by cystic fibrosis to provide input, insights and perspectives

Read More
Quebec lists Trikafta for reimbursement, offering new hope for Quebecers living with Cystic fibrosis
September 29, 2021

Cystic Fibrosis Canada calls on remaining provinces to save lives and list Trikafta immediately

Read More
Cystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs
September 24, 2021

Cystic Fibrosis Canada applauds Ontario, Alberta, and Saskatchewan for listing Trikafta under public drug benefit programs 

Read More